Navigation Links
MEI Pharma To Host Annual Meeting Of Stockholders
Date:3/20/2013

9% (eight out of nine). The Company plans to initiate a randomized, placebo-controlled Phase II trial of Pracinostat in combination with azacitidine in patients with MDS in June 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PQA and CECity Launch Joint Venture to Deliver First National Pharmacy Quality Measurement, Benchmarking and Reporting Platform for Pharmacies and Health Plans
2. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
3. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
4. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
5. Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
6. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston
8. National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
9. Pharmaceutical Distribution Agreement Between Cardinal Health And Walgreens To End August 2013
10. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
11. Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... EAST RUTHERFORD, N.J. , May 27, 2015  Cambrex ... Gregory Sargen , Executive Vice President and Chief Financial Officer, ... June 3, 2015 at 8:00 a.m. EDT in ... webcast and slide presentation can be accessed from the Cambrex ... "Webcasts & Presentations", and a replay will be available for ...
(Date:5/27/2015)... HANOVER, N.J. , May 27, 2015 /PRNewswire/ ... oncology portfolio in 21 medicines and 11 investigational ... the upcoming American Society of Clinical Oncology (ASCO) ... of the European Hematology Association (EHA), June 11-14. ... variety of cancer types, including melanoma, lung, breast, ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... the "Research and Future Development Trend Forecast of ... At present, there are 35,600 dialysis centers ... ratio are large due to the different regional operating ... centers in other Asian countries are operated by state-owned ...
Breaking Medicine Technology:Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 2Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 3Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 4Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 5Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 6Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 7Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 8China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
... the Consumer Healthcare Products Association (CHPA), announced Tammy Walsh as ... campaign to raise awareness of teen cough medicine ... boys and a high school math teacher from Northport, N.Y., ... substance abuse. Millions of Americans use medicines ...
... Dec. 15, 2011 Intellect Neurosciences, Inc. (OTCBB: ... and development of disease-modifying therapeutic agents for the ... today that it has filed an appeal regarding ... (EPO) to revoke the company,s ANTISENILIN® patents. The ...
Cached Medicine Technology:CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 3Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer 2Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer 3
(Date:5/27/2015)... 2015 Difass USA, a modern supplement ... with its first three flagship products, Dormiva™, Relaxiva™ and ... through http://www.difassusa.com . , A restful night’s ... but some people struggle with getting the full amount ... sleep aid designed to help you fall asleep and ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 On June ... advertising agency, will partner with LifeSource to host Donate ... will take place in a LifeSource donor coach outside ... to 4:00 p.m. , Demand for whole blood units ... Illinois, during the summer months. LifeSource requires approximately 1,000 ...
(Date:5/27/2015)... Genius Monkey is pleased to announce ... technology, they have boosted sales for the Utah Honda ... level for seven Utah-based dealers. , Until recently, ... radio media. In 2014 the Utah Honda dealers changed ... Genius Monkey , shifted their marketing campaigns more towards ...
(Date:5/27/2015)... 27, 2015 “Heroin has never been more ... overdoses are coming from,” says Harford County Sheriff Jeff Gahler, ... 8th. In the surging heroin related incidents in Baltimore, police ... education to prevent heroin addiction and subsequent abuse before it ... Drug Rehab Baltimore is a drug and alcohol rehab facility ...
(Date:5/27/2015)... 2015 SmarterSkin, http://www.smarterskindermatology.com , is taking ... test that makes it easier for patients to find skin ... , Dr. Sejal Shah is a cosmetic dermatologist based in ... offer the test. This revolutionary DNA test uses 16 genetic ... aging: , 1. Firmness and elasticity , 2. ...
Breaking Medicine News(10 mins):Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2
... ... Accident Helpline warns of the dangers of cycling injuries and urges caution on the roads ... (PRWEB) June 14, 2010 -- National Accident ... now the improving weather is seeing an increasing number of people take to their bikes, often ...
... ... non-smoking environment in all 231 guest rooms and 17,000 sq feet of meeting space, effective ... Silver ... has taken one more step to “going green”, effective June 14 the Hotel will be ...
... before age 18 are much more likely as adults to ... injuring their partners, according to a new study. This ... intervention with suicidal teens. It is based on data from ... ages 10 to 32, and their romantic partners who participated ...
... ... Seconds , ... Heartbreaking is the only way to describe Dan McGehee’s third attempt at the 100-mile cycling ... his daughter Hope was born. Today, he missed the record by only 4 minutes and 57 ...
... ... to announce the relaunch of their website personalcarewholesaler.com, due to popular demand for an ... website offers wholesale pricing on thousands of personal care products. , ... (PRWEB) June 13, 2010 -- Personal ...
... danger to the blood supply, but urge more research , SATURDAY, ... and Human Services panel of experts on Friday voted to uphold ... more research on the controversial issue. , The current policy -- ... AIDS crisis -- prevents any man who since 1977 has had ...
Cached Medicine News:Health News:Break The Injury Cycle, Says National Accident Helpline 2Health News:Teen boys who attempted suicide more like to abuse partners as adults 2Health News:Teen boys who attempted suicide more like to abuse partners as adults 3Health News:American Doctor Misses World Cycling Record by 4 minutes, 57 Seconds 2Health News:Wholesale Pricing on Health & Beauty Products Now Available Nationwide at PersonalCareWholesaler.com 2Health News:U.S. Panel Upholds Ban on Gay Men as Blood Donors 2Health News:U.S. Panel Upholds Ban on Gay Men as Blood Donors 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: